USPTO serial 79351185
RBGALSTAR
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 2, 2024
- Examiner
- LAVACHE, LINDA M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with RBGALSTAR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Zhi Dong
Hamre Schumann Muller & Larson, P.C.45 South Seventh Street, Suite 2700Minneapolis, MN 55402UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Industrial chemicals, namely, glucosides; carbonic hydrates; polymer resins, unprocessed; artificial resins, unprocessed; chemical preparations in the nature of ion-exchange resins; enzymes for industrial purposes; enzymes for the food industry; biochemical catalysts; industrial chemicals; chemical preparations for scientific purposes, other than for medical or veterinary use | ACTIVE | — |
| 005 | Medicines for humans for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; chemico-pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; biological preparations for medical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; chemical preparations for pharmaceutical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; chemical preparations for medical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; crude drugs being pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, and genetic disorders; pharmaceuticals for the treatment of cancer; pharmaceuticals for the treatment of infectious diseases; diagnostic preparations for medical purposes; dietetic substances adapted for medical use, namely, dietary supplements and dietetic foods adapted for medical use; depuratives for the body; pharmaceutical preparations for the treatment of hypercholesteremia; pesticides; pharmaceutical preparations for the treatment of hyperlipidemia; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; anticoagulants; medicines for veterinary purposes for the treatment of gastrointestinal diseases and condition; cardiovascular pharmaceuticals; pharmaceutical preparations for ocular or intraocular surgery; dressings, medical; composite materials for dental purposes; diapers for pets | ACTIVE | — |
| 042 | Technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; development of pharmaceutical preparations and medicines; pharmaceutical product evaluation; pharmaceutical research and development services; research in the field of pharmaceuticals; quality control for others; scientific research; chemical research and analysis; development and testing of chemical production methods; biochemistry research services; medical and scientific research, namely, conducting clinical trials for others; medical research; testing of pharmaceuticals; industrial design | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Suzhou Ribo Life Science Co., Ltd.
- Other trademarks owned by Suzhou Ribo Life Science Co., Ltd.
- Other trademarks owned by Suzhou Ribo Life Science Co., Ltd.
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named RBGALSTAR
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 2, 2024 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Oct 16, 2024 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Oct 16, 2024 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 3, 2024 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 2, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 2, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 25, 2024 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Mar 6, 2024 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Mar 6, 2024 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 16, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 16, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 13, 2024 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 27, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 27, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Dec 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 12, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 12, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 12, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 12, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 12, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 7, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 7, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 7, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 10, 2023 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jun 15, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 14, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 5, 2023 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 4, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 2, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 4, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 30, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 29, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |